Hideaki Bando

机构：National Cancer Center Hospital East

发表论文 3 篇

代表论文

• A phase 2 randomized study comparing telisotuzumab adizutecan monotherapy with standard of care in patients with post-adjuvant circulating tumor DNA–positive colorectal cancer. (2026 · Journal of Clinical Oncology)
• Clinical impact of R0 resection after chemotherapy in initially unresectable metastatic colorectal cancer: A pooled analysis of the ARCAD database. (2026 · Journal of Clinical Oncology)
• Organ preservation strategy using dostarlimab for dMMR/MSI-H resectable solid tumors with whole-genome–based MRD monitoring (D-CURE: EPOC2401). (2026 · Journal of Clinical Oncology)